130 related articles for article (PubMed ID: 2835975)
1. The in vitro 5-lipoxygenase and cyclo-oxygenase inhibitor L-652,343 does not inhibit 5-lipoxygenase in vivo in human skin.
Barr RM; Black AK; Dowd PM; Koro O; Mistry K; Isaacs JL; Greaves MW
Br J Clin Pharmacol; 1988 Jan; 25(1):23-6. PubMed ID: 2835975
[TBL] [Abstract][Full Text] [Related]
2. Lipoxygenase products of arachidonic acid in human inflamed skin.
Black AK; Barr RM; Wong E; Brain S; Greaves MW; Dickinson R; Shroot B; Hensby CN
Br J Clin Pharmacol; 1985 Sep; 20(3):185-90. PubMed ID: 2994700
[TBL] [Abstract][Full Text] [Related]
3. Arachidonic acid-induced pleurisy (ARIP): an in vivo model for testing 5-lipoxygenase inhibition.
Boctor AM; Burke C; Hovinga ME
Methods Find Exp Clin Pharmacol; 1987 Dec; 9(12):793-7. PubMed ID: 2831442
[TBL] [Abstract][Full Text] [Related]
4. Pharmacology of the dual inhibitor of cyclooxygenase and 5-lipoxygenase 3-hydroxy-5-trifluoromethyl-N-(2-(2-thienyl)-2-phenyl-ethenyl)-benzo (b)thiophene-2-carboxamide.
Bailey PJ; Dallob AL; Allison DL; Anderson RL; Bach T; Durette PL; Hand KM; Hopple SL; Luell S; Meurer R
Arzneimittelforschung; 1988 Mar; 38(3):372-8. PubMed ID: 3132928
[TBL] [Abstract][Full Text] [Related]
5. Selective inhibition of arachidonate 5-lipoxygenase by novel acetohydroxamic acids: biochemical assessment in vitro and ex vivo.
Tateson JE; Randall RW; Reynolds CH; Jackson WP; Bhattacherjee P; Salmon JA; Garland LG
Br J Pharmacol; 1988 Jun; 94(2):528-39. PubMed ID: 2840160
[TBL] [Abstract][Full Text] [Related]
6. Skin levels of arachidonic acid-derived inflammatory mediators and histamine in atopic dermatitis and psoriasis.
Ruzicka T; Simmet T; Peskar BA; Ring J
J Invest Dermatol; 1986 Feb; 86(2):105-8. PubMed ID: 3018086
[TBL] [Abstract][Full Text] [Related]
7. Topical steroid treatment reduces arachidonic acid and leukotriene B4 in lesional skin of psoriasis.
Wong E; Barr RM; Cunningham FM; Mistry K; Woollard PM; Mallet AI; Greaves MW
Br J Clin Pharmacol; 1986 Dec; 22(6):627-32. PubMed ID: 3032226
[TBL] [Abstract][Full Text] [Related]
8. Meclofenamate sodium is an inhibitor of both the 5-lipoxygenase and cyclooxygenase pathways of the arachidonic acid cascade in vitro.
Boctor AM; Eickholt M; Pugsley TA
Prostaglandins Leukot Med; 1986 Aug; 23(2-3):229-38. PubMed ID: 3020588
[TBL] [Abstract][Full Text] [Related]
9. Increased biosynthesis of lipoxygenase products by UVB-irradiated guinea pig epidermis: evidence of a cyclooxygenase inhibitor.
Burrall B; Ziboh VA
J Invest Dermatol; 1986 Jun; 86(6):643-8. PubMed ID: 3086462
[TBL] [Abstract][Full Text] [Related]
10. Effects of two novel inhibitors of 5-lipoxygenase, L-651,392 and L-651,896, in a guinea-pig model of epidermal hyperproliferation.
Chan CC; Dubois L; Young V
Eur J Pharmacol; 1987 Jul; 139(1):11-8. PubMed ID: 2820754
[TBL] [Abstract][Full Text] [Related]
11. Selective inhibition of arachidonate 5-lipoxygenase by novel acetohydroxamic acids: effects on acute inflammatory responses.
Higgs GA; Follenfant RL; Garland LG
Br J Pharmacol; 1988 Jun; 94(2):547-51. PubMed ID: 2840161
[TBL] [Abstract][Full Text] [Related]
12. Effect of inhibition of 5-lipoxygenase metabolism of arachidonic acid on response to endotoxemia in sheep.
Coggeshall JW; Christman BW; Lefferts PL; Serafin WE; Blair IA; Butterfield MJ; Snapper JR
J Appl Physiol (1985); 1988 Sep; 65(3):1351-9. PubMed ID: 2846494
[TBL] [Abstract][Full Text] [Related]
13. Leukocyte recruitment in the subcutaneous sponge implant model of acute inflammation in the rat is not mediated by leukotriene B1.
Foster SJ; McCormick ME; Howarth A; Aked D
Biochem Pharmacol; 1986 May; 35(10):1709-17. PubMed ID: 3011012
[TBL] [Abstract][Full Text] [Related]
14. 2-substituted indazolinones: orally active and selective 5-lipoxygenase inhibitors with anti-inflammatory activity.
Foster SJ; Bruneau P; Walker ER; McMillan RM
Br J Pharmacol; 1990 Jan; 99(1):113-8. PubMed ID: 2110012
[TBL] [Abstract][Full Text] [Related]
15. The effect of etretinate on the cyclo-oxygenase and lipoxygenase products of arachidonic acid metabolism in psoriatic skin.
Wong E; Barr RM; Brain SD; Greaves MW; Olins LA; Mallet AI
Br J Clin Pharmacol; 1984 Oct; 18(4):523-7. PubMed ID: 6091710
[TBL] [Abstract][Full Text] [Related]
16. Pharmacologic and clinical effects of lonapalene (RS 43179), a 5-lipoxygenase inhibitor, in psoriasis.
Black AK; Camp RD; Mallet AI; Cunningham FM; Hofbauer M; Greaves MW
J Invest Dermatol; 1990 Jul; 95(1):50-4. PubMed ID: 2164070
[TBL] [Abstract][Full Text] [Related]
17. Synergistic enhancement of mitogen responses of human lymphocytes by inhibitors of cyclo-oxygenase and lipoxygenase.
Blomgren H; Hammarström S; Wasserman J
Int Arch Allergy Appl Immunol; 1988; 86(1):62-8. PubMed ID: 3131257
[TBL] [Abstract][Full Text] [Related]
18. Selective 5-lipoxygenase inhibition in ulcerative colitis.
Laursen LS; Naesdal J; Bukhave K; Lauritsen K; Rask-Madsen J
Lancet; 1990 Mar; 335(8691):683-5. PubMed ID: 1969061
[TBL] [Abstract][Full Text] [Related]
19. Suppression of experimental autoimmune encephalomyelitis by dual cyclo-oxygenase and 5-lipoxygenase inhibition.
Prosiegel M; Neu I; Mallinger J; Wildfeuer A; Mehlber L; Vogl S; Hoffmann G; Ruhenstroth-Bauer G
Acta Neurol Scand; 1989 Mar; 79(3):223-6. PubMed ID: 2541593
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of action of glucocorticosteroids. Inhibition of T cell proliferation and interleukin 2 production by hydrocortisone is reversed by leukotriene B4.
Goodwin JS; Atluru D; Sierakowski S; Lianos EA
J Clin Invest; 1986 Apr; 77(4):1244-50. PubMed ID: 3007577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
